For instance, hydrophilic drugs such as trastuzumab (a monoclonal antibody) and gemcitabine (a nucleoside analogue) inhibit HER2 and TNBC, and thus these drugs have been used to treat early-stage and metastatic BC [25,38,40,41]. This evidence concerns the gene ERBB2 and breast cancer.